Sartorius Aktiengesellschaft (0NIQ.L)
EUR 183.2
(2.12%)
EUR 183.2
(2.12%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 6.99 Billion EUR | 61.36% |
| 2022 | 4.33 Billion EUR | 8.43% |
| 2021 | 3.99 Billion EUR | 27.73% |
| 2020 | 3.13 Billion EUR | 74.26% |
| 2019 | 1.79 Billion EUR | 14.38% |
| 2018 | 1.57 Billion EUR | 3.92% |
| 2017 | 1.51 Billion EUR | 46.74% |
| 2016 | 1.03 Billion EUR | 29.99% |
| 2015 | 792.48 Million EUR | 2.21% |
| 2014 | 775.36 Million EUR | 6.06% |
| 2013 | 731.07 Million EUR | 9.69% |
| 2012 | 666.46 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 6.01 Billion EUR | -1.88% |
| 2024 Q2 | 6.13 Billion EUR | -10.73% |
| 2024 Q1 | 6.86 Billion EUR | -2.2% |
| 2023 Q4 | 7.02 Billion EUR | -2.67% |
| 2023 FY | 7.02 Billion EUR | 61.96% |
| 2023 Q1 | 4.4 Billion EUR | 1.61% |
| 2023 Q2 | 4.33 Billion EUR | -1.61% |
| 2023 Q3 | 7.21 Billion EUR | 66.43% |
| 2022 Q3 | 4.58 Billion EUR | 14.31% |
| 2022 Q1 | 3.96 Billion EUR | -0.85% |
| 2022 FY | 4.33 Billion EUR | 8.43% |
| 2022 Q2 | 4 Billion EUR | 1.06% |
| 2022 Q4 | 4.33 Billion EUR | -5.33% |
| 2021 Q4 | 3.99 Billion EUR | 0.72% |
| 2021 Q2 | 3.58 Billion EUR | 0.0% |
| 2021 FY | 3.99 Billion EUR | 27.73% |
| 2021 Q1 | - EUR | -100.0% |
| 2021 Q3 | 3.97 Billion EUR | 10.83% |
| 2020 Q4 | 3.1 Billion EUR | 5.56% |
| 2020 Q3 | 2.94 Billion EUR | 9.21% |
| 2020 FY | 3.13 Billion EUR | 74.26% |
| 2020 Q1 | 1.79 Billion EUR | 1.08% |
| 2020 Q2 | 2.69 Billion EUR | 50.06% |
| 2019 Q3 | 1.73 Billion EUR | 2.05% |
| 2019 FY | 1.79 Billion EUR | 14.38% |
| 2019 Q4 | 1.77 Billion EUR | 2.56% |
| 2019 Q2 | 1.69 Billion EUR | 0.96% |
| 2019 Q1 | 1.68 Billion EUR | 8.15% |
| 2018 Q2 | 1.57 Billion EUR | 3.44% |
| 2018 Q3 | 1.62 Billion EUR | 3.01% |
| 2018 Q1 | 1.52 Billion EUR | 2.01% |
| 2018 FY | 1.57 Billion EUR | 3.92% |
| 2018 Q4 | 1.55 Billion EUR | -4.15% |
| 2017 Q2 | 1.54 Billion EUR | 3.02% |
| 2017 FY | 1.51 Billion EUR | 46.74% |
| 2017 Q4 | 1.49 Billion EUR | -2.68% |
| 2017 Q3 | 1.53 Billion EUR | -0.8% |
| 2017 Q1 | 1.49 Billion EUR | 47.53% |
| 2016 Q1 | 825.2 Million EUR | 4.13% |
| 2016 Q4 | 1.01 Billion EUR | -2.7% |
| 2016 Q3 | 1.04 Billion EUR | 2.42% |
| 2016 Q2 | 1.01 Billion EUR | 23.57% |
| 2016 FY | 1.03 Billion EUR | 29.99% |
| 2015 Q1 | 734.8 Million EUR | -5.23% |
| 2015 FY | 792.48 Million EUR | 2.21% |
| 2015 Q4 | 792.48 Million EUR | 3.32% |
| 2015 Q3 | 767 Million EUR | 2.84% |
| 2015 Q2 | 745.8 Million EUR | 1.5% |
| 2014 Q2 | 754.4 Million EUR | 5.96% |
| 2014 Q1 | 712 Million EUR | -2.61% |
| 2014 FY | 775.36 Million EUR | 6.06% |
| 2014 Q4 | 775.36 Million EUR | 2.43% |
| 2014 Q3 | 757 Million EUR | 0.34% |
| 2013 Q1 | 670.8 Million EUR | 0.65% |
| 2013 Q3 | 672.7 Million EUR | -0.55% |
| 2013 Q4 | 731.07 Million EUR | 8.68% |
| 2013 Q2 | 676.4 Million EUR | 0.83% |
| 2013 FY | 731.07 Million EUR | 9.69% |
| 2012 Q4 | 666.46 Million EUR | 0.0% |
| 2012 FY | 666.46 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Cegedim SA | 629.51 Million EUR | -1011.639% |
| Guerbet SA | 646.97 Million EUR | -981.642% |
| Nexus AG | 153.13 Million EUR | -4469.789% |
| Bastide Le Confort Médical SA | 566.34 Million EUR | -1135.631% |
| Revenio Group Oyj | 37.6 Million EUR | -18511.436% |
| Drägerwerk AG & Co. KGaA | 1.84 Billion EUR | -278.853% |
| LNA Santé SA | 1.19 Billion EUR | -483.83% |
| Siemens Healthineers AG | 28.55 Billion EUR | 75.49% |
| Medios AG | 125.94 Million EUR | -5456.27% |
| Equasens Société anonyme | 166.41 Million EUR | -4104.989% |
| Stratec SE | 246.2 Million EUR | -2742.306% |